Over 3,700 bottles of a three-drug olmesartan blood pressure pill recalled in the US after failing dissolution tests
- Macleods Pharma USA is recalling 3,744 bottles of olmesartan, amlodipine and hydrochlorothiazide tablets for high blood pressure.
- The FDA classified the olmesartan combination recall as Class II on 26 October 2026.
- The olmesartan combination tablets failed dissolution testing, so they may not dissolve properly.
- Brand-name Tribenzor is not included, and patients should not stop blood pressure medicine without advice.
New Jersey-based Macleods Pharma USA is recalling 3,744 bottles of a generic blood pressure tablet that combines olmesartan medoxomil 40 mg, amlodipine 10 mg and hydrochlorothiazide 12.5 mg, after the tablets failed dissolution specifications, meaning they may not dissolve properly. The US Food and Drug Administration classified the recall as Class II on 26 October 2026.
Recalled lots
The recall covers 3,528 bottles of 30 tablets from lot 12251163A (NDC 33342-246-07) and 216 bottles of 90 tablets from lot 12251163B (NDC 33342-246-10), both expiring 31 May 2027. The tablets were made in India and distributed nationwide. Brand-name Tribenzor, which contains the same three ingredients, is not included.
Also read: 22 vials of compounded tirzepatide recalled in the US over lack of sterility assurance
How serious is it?
Class II means the medicine may cause temporary or medically reversible health problems, while serious harm is unlikely. The FDA says patients can generally keep using medicine in a Class II recall unless the company or the agency says otherwise.
What patients should do
Check the medicine name, maker and lot number on the bottle. Do not stop a blood pressure medicine on your own; contact your pharmacist or doctor to arrange a replacement. If your pills were moved into a pharmacy bottle, the lot number may not appear, so ask the pharmacy that filled it.
Sources: AARP, FOX 5 New York
This story is relayed from the source named above; responsibility for its content rests with the original source.
FAQ
Which blood pressure medicine was recalled in October 2026?
Macleods recalled generic tablets combining olmesartan 40 mg, amlodipine 10 mg and hydrochlorothiazide 12.5 mg for high blood pressure.
Why were the olmesartan combination tablets recalled?
Macleods' olmesartan combination tablets were recalled because they failed dissolution testing, so they may not dissolve properly in the body.
Which olmesartan lots are recalled?
The recalled olmesartan combination lots are 12251163A (30-tablet bottles) and 12251163B (90-tablet bottles), both expiring 31 May 2027.
Does the olmesartan recall include brand-name Tribenzor?
No. The olmesartan combination recall covers only Macleods' generic product, not brand-name Tribenzor.
Should recalled olmesartan tablets be stopped immediately?
Recalled olmesartan tablets should not be stopped without advice; patients should contact a pharmacist or doctor for a replacement, as patients are advised not to stop blood pressure medicine without medical advice.


